面议 中文名：达帕托霉素中文别名：达托霉素; 达妥霉素英文名称：Daptomycin英文别名：Benzenebutanoic acid, N-(1-oxodecyl)-L-tryptophyl-D-asparaginyl-L-a-asparty
基于528个网页-相关网页
Daptomycin for Injection 注射用达托霉素
Daptomycin BPR 达普霉素
Cubicin Daptomycin 达托霉素
daptomycin precursor 达托霉素前体
Daptomycin was approved by FDA in 2003, and it was used in skin and soft tissue infection.
2003年,达托霉素被FDA批准在美国上市,主要用于皮肤和软组织感染治疗。
参考来源 - 达托霉素高产菌株选育及发酵条件优化Daptomycin is a novel lipopeptide antibiotic which was produced by Streptomyces roseosporus and can resist to most gram-positive bacteria.
达托霉素是一种新型脂肽类抗生素,由玫瑰孢链霉菌发酵生成,具有在体外抗绝大多数临床革兰氏阳性菌的作用。
参考来源 - 玫瑰孢链霉菌代谢通量分析及戊糖磷酸途径改造·2,447,543篇论文数据，部分数据来源于NoteExpress
Daptomycin is now a commercial success.
如今，达托霉素在商业上获得了巨大成功。
A new drug was found, daptomycin, to treat infective endocarditis.
于是出现了治疗感染性心内膜炎的新药——达托霉素。
The invention relates to a daptomycin synthesis method for resolving the technical problem of prior art which uses rose spore streptomycete as raw material to cost high synthesis cost.
本发明涉及一种达托霉素的合成方法。主要解决现有以玫孢链霉菌作为原料 合成成本过高的技术问题。
应用推荐